PolyMedica Industries adds new vice president of marketing.

WOBURN, Mass.--(BUSINESS WIRE)--Oct. 1, 1996--PolyMedica Industries, Inc. (AMEX:PM) today announced the appointment of Randy Sloan to the newly-created position of Vice President of Marketing.

The creation of this position signals the Company's strategic decision to assume greater control over major aspects of the marketing and distribution of its diverse product offerings, with particular emphasis on increasing penetration in the over-the-counter (OTC) marketplace.

For the past 12 years, Mr. Sloan has been with Ciba Self-Medication, Inc., a $750 million consumer division of Ciba-Geigy Corporation. He most recently held the position of Vice President - Marketing, with direct responsibility for leading all marketing efforts, including brand management, market research and consumer affairs. He also managed the new product efforts of Ciba's OTC product lines including Maalox, Habitrol, Desenex, Dulcolax and Doan's, Eucalyptamint, and Sunkist Vitamin C Rolls, all of which prospered under his leadership. In addition, he helped integrate Ciba's acquisition of Fisons' health care business.

Prior to his successful career at Ciba, Mr. Sloan was at Tambrands, Inc., where he was the Product Manager for Tampax Tampons; before that he was Product Manager at Colgate-Palmolive Company responsible for Fresh Start, Ajax Cleanser, and Handi-Wipes. He holds an M.B.A. with Honors from the University of Chicago and a Bachelor of Science in Finance and Accounting, Cum Laude, from the University of Pennsylvania.

Steven J. Lee, PolyMedica's Chairman and Chief Executive Officer, said, "Randy's extensive marketing knowledge and OTC consumer healthcare orientation provide us with the expertise necessary to take full advantage of our technology-based healthcare products. He is a proven leader with an impressive track record in introducing new products, increasing sales of products currently on the market, and integrating acquired products, as well as achieving substantial P&L improvement.

"At PolyMedica, Randy will oversee all aspects of our marketing efforts, with initial emphasis on increasing the penetration of AZO-STANDARD and AZO- CRANBERRY. He will also assume direct responsibility for the upcoming launch of our proprietary, microenvironmental wound dressings into the $450 million OTC wound care market," Mr. Lee added.

Mr. Sloan stated, "I am very excited about the tremendous marketing potential that I perceive at PolyMedica. The Company has a very strong portfolio of quality products with broad market appeal, and it is dedicated to increasing marketing and distribution, as evidenced by the recent acquisition of Liberty Medical which opened the catalog mail-order distribution channel for PolyMedica. I believe the Company is poised to move forward and hope to help lead the way."

PolyMedica Industries, Inc. develops, manufactures, and distributes specialized healthcare products to national and international niche markets in which the Company strives to establish a preeminent market position.

This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such statements as a result of various factors, including those discussed in the Company's Forms 10-K and 10-Q on file with the SEC.

CONTACT: PolyMedica Industries, Inc. Sitrick And Company

Steven J. Lee Jeff Lloyd/Jody Martin

Chairman and CEO  [phone]

[phone] Anne George 

[phone]